Document is current
Any future updates will be listed below
-
Authors
Bao, Zhiheng
Liu, Zhimin
Zhang, Zhaoyong
Wang, Xuanjia
Jin, Xiaohui
Bai, Jiaxiu
Ma, Hanwen
Li, Yaxin
Yi, Chunyan
Ling, Zhiyang https://orcid.org/0000-0001-8873-6773
Huang, Zhong https://orcid.org/0000-0002-2161-1359
Zhang, Lu https://orcid.org/0009-0003-7289-1578
Chen, Zhenguo https://orcid.org/0000-0003-4748-9299
Xie, Youhua https://orcid.org/0000-0002-2416-7708
Wang, Yanqun https://orcid.org/0000-0003-4676-2812
Sun, Lei https://orcid.org/0000-0001-8741-0202
Sun, Xiaoyu https://orcid.org/0009-0000-1265-4544
- License Information
-
More Information
Article History
Received: 12 January 2025
Accepted: 30 March 2026
First Online: 6 May 2026
Competing interests
: The patent application for antibody 76E1 (International Publication No. WO2022148374A1) was filed by the Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, and includes X.S., C.Y. and Z. Ling as inventors. The patent has been granted in China (CN202110008031.1) and Japan (JP2023541020), and is pending in the European Union (EP22736536) and the United States (US18270917). This patent covers antibody 76E1 and its related sequences. The other authors declare no competing interests.
